Invivyd, Inc. (IVVD)

NASDAQ

$0.65

$-0.02

(-2.48%)

Regular Market

Invivyd, Inc. (IVVD) Live Price Chart

Last updated: ⁦2026-10-13 15:05:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Invivyd, Inc. (IVVD) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0.65, with a market capitalisation of $212.58M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.53 to $3.07. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$212.58M
Open	$0.66
Day's High	$5.20
Day's Low	$0.35
Previous Close	$0.67
Volume	1.19M
Average Volume	4.97M
P/E Ratio	--
52-Week High	$3.07
52-Week Low	$0.53
Dividend Yield	--
Earnings Date	--

Invivyd, Inc. (IVVD) Stock Price Today

Invivyd, Inc. (IVVD) is currently trading at $0.65 as of 2026-10-13 14:48:42, down 3.02% ($0.02) from the previous close of $0.67

During today's regular trading session, IVVD has traded between $0.35 and $5.20, with a trading volume of 1.19M shares. The current price is near the lower end of today's range.

Invivyd, Inc. (IVVD) 7-Day Stock Price Change

Over the past seven days, Invivyd, Inc. (IVVD) moved from $0.82 to $0.65, representing a decline of 20.57% ($0.17).

The stock traded between $0.65 and $0.85 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 6.16 million shares, down versus the previous seven-day period, indicating lower trading activity.

IVVD 52-Week Price Position

Position in Range: 4.9%

52W Low$0.53

52W High$3.07

IVVD is currently trading at $0.65, placing it 4.9% of the way from its 52-week low of $0.53 to its 52-week high of $3.07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Invivyd, Inc. (IVVD)?

Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.

Invivyd, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	122
Exchange	NASDAQ
Company Website	https://www.invivyd.com

How to Buy Invivyd, Inc. (IVVD) Stock on MEXC

Eligible investors can buy real shares of Invivyd, Inc. (IVVD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for IVVD and Place Your Order

Open the RealStocks trading page and search for IVVD. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Invivyd, Inc. (IVVD) stock price today?

Invivyd, Inc. (IVVD) is currently trading at $ 0.65, down 3.02% ($0.02) from the previous close of $ 0.67. Intraday prices update in real time during regular trading hours.

2.Is IVVD stock going up or down today?

As of 2026-10-13 14:48:42, IVVD is trading at $ 0.65, down 3.02% ($0.02) from its previous close of $ 0.67. The stock has traded between $ 0.35 and $ 5.20 during today’s regular session. Past price movements do not guarantee future results.

3.What is IVVD pre-market price?

As of 2026-10-13 14:48:42, IVVD is trading at $ 0.67 in pre-market trading, down 0.34% ($0.00) from the previous close of $ 0.67. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is IVVD after-hours price?

As of 2026-10-13 14:48:42, IVVD is trading at $ 0.69 in after-hours trading, up 1.74% ($0.01) from the regular-session close of $ 0.67. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is IVVD stock trading now?

IVVD trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does IVVD sit relative to its 52-week high and low?

Over the past 52 weeks, IVVD has traded between a low of $ 0.53 and a high of $ 3.07. At $ 0.65, the stock is positioned 4.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Invivyd, Inc. in?

Invivyd, Inc. (IVVD) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Invivyd, Inc.'s market capitalisation and where is it listed?

Invivyd, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 212.58M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is IVVD valued in terms of P/E ratio and EPS?

IVVD trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.36. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Invivyd, Inc. pay a dividend?

Invivyd, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.